PHARM
INTERMEDIATE
Why Choose PHILCHEM?
“The most reliable global sourcing solution, from early-stage R&D to commercial mass production.”
As competition in new drug R&D and alternative process development, the rapid procurement of high-purity intermediates and fine reagents has become a core competitive advantage for pharmaceutical companies. Based on over 20 years of accumulated expertise in fine chemicals and raw material imports, PHILCHEM directly connects verified top-tier global manufacturers with domestic pharmaceutical companies.
Going beyond simple raw material distribution, we perfectly meet the stringent impurity profile requirements of our clients’ research institutes and guarantee a seamless supply chain—from small lab-scale samples to ton-scale commercial supply. PHILCHEM is your most reliable and trusted partner in shortening synthesis processes and realizing cost reductions.
[Top 20 Core Intermediate Portfolios Optimized for the Synthesis and CDMO Market]
| Category | Intermediate Name | Target Drug & Trend | Key Sourcing Point |
| Peptides & Obesity/Diabetes | SNAC (Salcaprozate Sodium) | Oral GLP-1 (e.g., Semaglutide) | An essential absorption enhancer for oralizing obesity drug pipelines; the #1 priority for R&D departments. |
| GLP-1 Side Chains | Long-acting peptide obesity treatments | Lipid side chains that maintain peptide efficacy; demand is surging due to large-scale production expansions. | |
| CTC Resin / Wang Resin | Solid-phase peptide synthesis (SPPS) | Essential resins for peptide synthesis; directly impacts yield, making it crucial to secure high-quality vendors. | |
| HATU, COMU | Peptide and amino acid coupling | Premium coupling reagents with overwhelmingly high yields, essential for complex new drug synthesis. | |
| Next-Gen Modalities (ADC & RNA) | ADC Linkers (e.g., Mc-Vc-PAB) | Antibody-Drug Conjugate (ADC) anti-cancer drugs | High-value linker materials in the ADC sector, which companies are rushing into to secure global CDMO contracts. |
| Phosphoramidites | Oligonucleotides (siRNA, mRNA) | Core building blocks in the RNA-based raw material market. | |
| Ionizable Lipids / PEG Lipids | LNP (Lipid Nanoparticle) delivery systems | Ultra-high-cost lipid materials acting as capsules to deliver mRNA vaccines and treatments into the body. | |
| Domestic Blockbuster New Drugs | Tegoprazan Intermediate | P-CAB Gastrointestinal Drug (K-CAB) | An essential target for developing generics and incrementally modified drugs for domestic blockbusters with overwhelming prescription sales. |
| Fexuprazan Intermediate | P-CAB Gastrointestinal Drug (Fexuclue) | High demand for ultra-precision synthesis at the research level to bypass patents of leading P-CAB products. | |
| Oncology & Highly Difficult Chiral | Osimertinib Intermediate | NSCLC Targeted Therapy (Tagrisso) | A highly profitable oncology API with massive demand for high-purity intermediates that can shorten the process. |
| Deruxtecan Intermediate | Next-Gen Breast/Gastric Cancer ADC (Enhertu) | The core payload (toxic drug) intermediate of the product leading the global anti-cancer market. | |
| Sacubitril Chiral Intermediate | Chronic Heart Failure (Entresto) | An essential chiral material for generic development; discovering vendors that guarantee high optical purity is the key to success. | |
| Palbociclib Intermediate | Breast Cancer Targeted Therapy (Ibrance) | A pyridopyrimidine structure material preferred by factories aiming to maximize added value through in-house synthesis. | |
| Enzalutamide Intermediate | Prostate Cancer Treatment (Xtandi) | A high-cost material optimized for pharmaceutical companies seeking to reduce API import costs and promote in-house synthesis. | |
| Sterile & High-Quality Antibiotics | Cephalosporin Side Chains | Cephalosporin & Carbapenem Antibiotics | Constant sourcing of low-cost, high-quality side chains is required to maintain export competitiveness of finished products. |
| Tazobactam Intermediate | Beta-Lactamase Inhibitor Combination Antibiotics | A steady demand item at the ton scale for dedicated factories synthesizing high-purity sterile injectable antibiotics. | |
| General & Fine Reagents | Chiral Resolving Agents | Optical Isomer Separation | Premium reagents used to isolate only the necessary isomers, becoming mandatory due to tightening quality regulations. |
| Boc-Anhydride | Amine Protecting Reagent | A consumable used by the ton in almost all API synthesis plants, ensuring a solid base cargo volume. | |
| Silica Gel (Chromatography) | High-Purity API Purification | Consumption of large-scale purification silica gel has skyrocketed due to stricter API purification standards. | |
| Metal Catalysts | Precious Metal Catalytic Reactions (e.g., Palladium) | High-priced metal catalysts essential for modern pharmaceutical synthesis, such as Suzuki coupling. |
Why Pharmaceutical Companies Must Pay Attention to These Core Intermediates
“The Key to Securing Global CDMO Competitiveness and Successful High-Value R&D”
- Preempting the Next-Generation Modality Market: The market for next-generation treatments like peptides (obesity/diabetes) and ADCs (oncology) is expanding exponentially. This portfolio goes beyond simple generic competition, serving as an essential core weapon for pharmaceutical companies diving into high-value new drug R&D and global CDMO bidding wars.
- Responding to the Mega-Blockbuster Patent Cliff: The patent expirations of blockbuster drugs generating massive sales—such as Entresto, Tagrisso, and K-CAB—are imminent. Preemptively securing high-purity intermediates to support alternative process development and precise chiral synthesis will determine the success of market preemption.
- Breaking Through Regulatory Barriers and Accelerating R&D: Instead of going through the rigorous finished API registration (KDMF) process, importing high-quality intermediates and conducting the final processes domestically can dramatically accelerate a pharmaceutical company’s R&D speed and commercialization schedule.
- Overwhelming Cost Competitiveness and Impurity Control: Through a strong direct-deal network with leading global fine chemical vendors in India, China, and elsewhere, we supply high-quality materials with perfectly controlled impurities (such as NDMA) at the most economical unit prices, thereby maximizing your final operating profit margins.
